Patents by Inventor David Stirling

David Stirling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060069126
    Abstract: Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group, which may be further substituted in the 5-position with alkyl or halogeno, and in the 4-position with alkyl or a nitrogen-containing group are inhibitors of, and thus useful in the treatment of disease states mediated by, TNF?. A typical embodiment is 2-(2,6-dioxo-3-hydroxy-5-fluoro-piperidin-5-yl)4-aminoisoindolin-1-one.
    Type: Application
    Filed: November 4, 2005
    Publication date: March 30, 2006
    Inventors: George Muller, Hon-Wah Man, David Stirling
  • Publication number: 20060030587
    Abstract: Methods for treating Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, AIDS Dementia Complex and cognitive decline in HIV-AIDS while minimizing drug hypersensitivity, toxicity, side effects, euphoric effect, and drug abuse potential by administration of d-threo-methylphenidate or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: October 6, 2005
    Publication date: February 9, 2006
    Inventors: Andrew Zeitlin, Maghsoud Dariani, David Stirling
  • Publication number: 20050148034
    Abstract: The present invention relates to methods of identifying modulators of angiogenesis utilizing human cells. The methods of the invention can be employed to assay compounds and small molecules for their ability to modulate human angiogenesis utilizing human pluripotent stem cells in an in vitro assay system. The present invention further relates to methods of identifying modulators of human angiogenesis by determining the ability of a test compound to modulate spontaneous vasogenesis in an in vitro assay system utilizing nonembryonic pluripotent stem cells. The present invention relates to in vitro assay systems utilizing nonembryonic pluripotent stem cells for the identification of compounds that modulate human angiogenesis or human vasogenesis.
    Type: Application
    Filed: April 14, 2003
    Publication date: July 7, 2005
    Inventors: Robert Hariri, Faribourz Payvandi, Lei Wu, David Stirling, Qian Ye
  • Publication number: 20050131024
    Abstract: Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF? in a mammal. A typical embodiment is 1-oxo-2-(2,6-dioxo-3-methylpiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline.
    Type: Application
    Filed: January 14, 2005
    Publication date: June 16, 2005
    Inventors: George Muller, David Stirling, Roger Chen
  • Publication number: 20050119307
    Abstract: Methods for treating Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, AIDS Dementia Complex and cognitive decline in HIV-AIDS while minimizing drug hypersensitivity, toxicity, side effects, euphoric effect, and drug abuse potential by administration of d-threo-methylphenidate or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: October 8, 2004
    Publication date: June 2, 2005
    Inventors: Andrew Zeitlin, Maghsoud Dariani, David Stirling
  • Publication number: 20050118715
    Abstract: The present invention relates to methods of modulating mammalian stem cell and progenitor cell differentiation. The methods of the invention can be employed to regulate and control the differentiation and maturation of mammalian, particularly human stem cells along specific cell and tissue lineages. The methods of the invention relate to the use of certain small organic molecules to modulate the differentiation of stem or progenitor cell populations along specific cell and tissue lineages, and in particular, to the differentiation of embryonic-like stem cells originating from a postpartum placenta or for the differentiation of early progenitor cells to a granulocytic lineage. Finally, the invention relates to the use of such differentiated stem or progenitor cells in transplantation and other medical treatments.
    Type: Application
    Filed: April 11, 2003
    Publication date: June 2, 2005
    Inventors: Robert Hariri, David Stirling, Kyle Chan, Laure Moutouh-de Parseval
  • Publication number: 20050090516
    Abstract: Novel imides are inhibitors of tumor necrosis factor alpha and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is (R)-2-Phthalimido-3-(3?,4?-dimethoxyphenyl)propane.
    Type: Application
    Filed: November 16, 2004
    Publication date: April 28, 2005
    Inventors: George Muller, Mary Shire, David Stirling
  • Patent number: 6743325
    Abstract: A flexible material includes a plurality of separate resilient elements joined to a flexible, resiliently stretchable substrate. Such a material is suitable for providing protective war for human and animal bodies. Preferably, the elements includes a foam material such as a closed cell polyethylene foam and the substrate includes a knitted fabric. In an advantageous embodiment, a second flexible substrate is bonded over the elements to sandwich them between the two layers of substrate.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: June 1, 2004
    Assignee: Stirling Moulded Composites Limited
    Inventor: David Stirling Taylor
  • Patent number: 6380239
    Abstract: 1-Oxo- and 1,3-dioxoisoindolines substituted in the 4- or 5-position of the indoline ring reduce the levels of inflammatory cytokines such as TNF&agr; in a mammal. A typical embodiment is 4-(4-amino-1,3-dioxoisoindolin-2-yl)-4-carbamoylbutanoic acid.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: April 30, 2002
    Assignee: Celgene Corporation
    Inventors: George W. Muller, David Stirling
  • Patent number: 6368110
    Abstract: In general, an educational homeroom provides a central location for a student to receive and interact with educational tools and information that are focused upon a Knowledge Area in which the student has expressed educational interest. When the student expresses educational interest, the educational homeroom dynamically changes such that options made available to the student are always tailored to offer educational tools and information within the student's Knowledge Areas of choice.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: April 9, 2002
    Assignee: Epic Learning
    Inventors: Lynne Koenecke, Jennifer Hart, Burr Warne, David Stirling, Scott Bain, Clint Crowe
  • Patent number: 6370355
    Abstract: In general, an Internet based blended learning system provides educational tools to a student in accordance with the student's expressed educational interests. The blended learning system uses multiple educational tools that are tailored toward providing the end-user with complete and efficient educational lessons. Each tailored educational tool is focused upon a knowledge area in which the student has expressed educational interest. Students may complete each educational tool at their own pace, repeat lessons as necessary, and learn according to their own schedule. The blended learning system uses combinations of instructor-led virtual classrooms (I-led), online coaching, interactive computer based training (CBT), knowledge databases, published study guides and books, hands-on exercise labs and/or pre-certification exams.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: April 9, 2002
    Assignee: Epic Learning, Inc.
    Inventors: Craig Ceretta, Burr Warne, David Stirling, Scott Bain
  • Patent number: 4046926
    Abstract: This invention relates to non-dairy creamer compositions and, in particular, to non-dairy creamers based on sodium caseinate and having improved resistance to feathering.
    Type: Grant
    Filed: July 30, 1976
    Date of Patent: September 6, 1977
    Assignee: General Foods Ltd.
    Inventor: David Stirling Gardiner
  • Patent number: D484805
    Type: Grant
    Filed: June 6, 2002
    Date of Patent: January 6, 2004
    Assignee: The Dial Corporation
    Inventors: Joseph Calvin Colangelo, Heather A. Schneider, David Stirling Clelland